April 3, 2018 / 11:31 PM / 4 months ago

BRIEF-IDT Australia To Divest Selection Of Generic Product Portfolio To Ani Pharmaceuticals

April 4 (Reuters) - IDT Australia Ltd:

* TO DIVEST A SELECTION OF ITS GENERIC PRODUCT PORTFOLIO TO ANI PHARMACEUTICALS INC

* ‍IDT WILL RECEIVE US$2.7 MILLION

* ‍IDT WILL RETAIN A SHARE OF NET PROFIT FROM PRAZOSIN FUTURE SALES FOR 60 MONTHS​

* WILL RETAIN RIGHT TO MANUFACTURE AND SUPPLY DOXAZOSIN MESYLATE AND CALCIUM LEUCOVORIN ON A CONTRACT MANUFACTURE FOR PROFIT BASIS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below